Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Drug Information » Recently Approved Drugs » 1996
Medical Areas: Ophthalmology | Pulmonary/Respiratory Diseases

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: OcuHist

Company: Pfizer
Approval Status: Approved January 1996
Treatment Area: itching and redness of the eye

General Information

OcuHist has been approved as an over-the-counter antihistamine eye drop. Akorn, previously marketed this formulation as the prescription drug AK-Con-A.

With its active antihistamine ingredient pheniramine maleate (0.3%), and decongestant ingredient naphazoline hydrochloride (0.025%), OcuHist temporarily relieves itching and redness of the eye due to pollen, ragweed, grass, animal hair, and dander.

Additional Information

An estimated 50 million Americans are afflicted by pollen, ragweed, and other irritants.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.